Telescope Innovations Past Earnings Performance
Past criteria checks 0/6
Telescope Innovations has been growing earnings at an average annual rate of 10.7%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 100% per year.
Key information
10.7%
Earnings growth rate
34.4%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 100.0% |
| Return on equity | -45.8% |
| Net Margin | -27.0% |
| Last Earnings Update | 31 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Telescope Innovations makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 May 24 | 4 | -1 | 4 | 0 |
| 29 Feb 24 | 4 | -1 | 4 | 0 |
| 30 Nov 23 | 4 | 0 | 3 | 0 |
| 31 Aug 23 | 3 | -1 | 3 | 0 |
| 31 May 23 | 3 | -1 | 4 | 0 |
| 28 Feb 23 | 2 | -2 | 4 | 0 |
| 30 Nov 22 | 1 | -5 | 5 | 0 |
| 31 Aug 22 | 1 | -6 | 5 | 0 |
| 31 May 22 | 0 | -6 | 4 | 0 |
| 28 Feb 22 | 0 | -8 | 3 | 0 |
| 30 Nov 21 | 0 | -5 | 1 | 0 |
| 31 Aug 21 | 0 | -4 | 1 | 0 |
| 31 May 21 | 0 | -3 | 0 | 0 |
| 28 Feb 21 | 0 | 0 | 0 | 0 |
| 30 Nov 20 | 0 | 0 | 0 | 0 |
Quality Earnings: TELI is currently unprofitable.
Growing Profit Margin: TELI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TELI is unprofitable, but has reduced losses over the past 5 years at a rate of 10.7% per year.
Accelerating Growth: Unable to compare TELI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TELI is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).
Return on Equity
High ROE: TELI has a negative Return on Equity (-45.79%), as it is currently unprofitable.